About WAYPATH PHARMA LLC
WayPath Pharma is a biotechnology company focused on developing groundbreaking anti-cancer treatments for canines, with a pipeline advanced through pre-clinical testing and a canine pilot study showing significant efficacy. The company is led by experts in oncology and medicinal chemistry and has received NIH STTR grants to support its research.
Compound formulation and pre-clinical testingCanine clinical trials and pilot studiesDrug development and GMP synthesisComputational drug design using CNS-MPO and BBB_Score algorithmsToxicology studies in canines
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to WAYPATH PHARMA LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.